Literature DB >> 21526707

Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible?

Jonathan Fallowfield1, Peter Hayes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21526707      PMCID： PMC5922747          DOI： 10.7861/clinmedicine.11-2-179

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  5 in total

1.  Quantitative analysis of real-time tissue elastography for evaluation of liver fibrosis.

Authors:  Ying Shi; Xing-Hua Wang; Huan-Hu Zhang; Hai-Qing Zhang; Ji-Zheng Tu; Kun Wei; Juan Li; Xiao-Li Liu
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.

Authors:  Ning-Li Chai; Qiang Fu; Hui Shi; Chang-Hao Cai; Jun Wan; Shi-Ping Xu; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

3.  Liver function tests in identifying patients with liver disease.

Authors:  Zohair Ahmed; Umair Ahmed; Saqib Walayat; Jinma Ren; Daniel K Martin; Harsha Moole; Sean Koppe; Sherri Yong; Sonu Dhillon
Journal:  Clin Exp Gastroenterol       Date:  2018-08-23

4.  The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis.

Authors:  Suhyun Park; Seon In Hwang; Jonghun Kim; Seoyeon Hwang; Sohee Kang; Sera Yang; Jonghwa Kim; Wonseok Kang; Kyun-Hwan Kim; Dong Wook Han; Yong-Han Paik
Journal:  Stem Cell Res Ther       Date:  2019-01-11       Impact factor: 6.832

5.  Nuclear magnetic resonance evaluation of inflammatory activity from chronic viral Hepatitis B.

Authors:  Jinghui Dong; Yuan Liu; Huiyi Ye; Weimin An; Hongwei Ren
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.